July 15, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Twice daily sirolimus gel 0.2% was effective and safe for the treatment of acanthosis nigricans, a common dermatologic condition that predominantly affects people with skin of color, according to a study. Participants saw a significant reduction in the pigmentation of the plaques within 12 weeks, with the earliest signs of improvements appearing at week 4, according to findings published in the
July 15, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Once-daily ritlecitinib demonstrated clinically meaningful improvements in nonsegmental vitiligo on the face and body in adults…

A diagnosis of post-inflammatory hyperpigmentation, even without apparent erythema, may ignore ongoing inflammatory disease that…

CHICAGO — In patients with acquired hypothalamic obesity, treatment with setmelanotide for 2.5 years was associated with…

NEW YORK — GLP-1 receptor agonists offer dermatologic benefits but the same medications can leave patients grappling with several…

As GLP-1 receptor agonists drive unprecedented weight loss, patients are achieving goal weights but face new aesthetic…

In this video from GlomCon Hawaii, Dana Rizk, MD, discusses the results of a phase 3 clinical trial concerning the safety and…